Furans, thiophenes and related heterocycles in drug discovery

Current Opinion in Drug Discovery and Development

Volumn 8, Issue 6, 2005, Pages 723-740

  Sperry, Jeffrey B ^a   Wright, Dennis L ^a  

^a Dartmouth College   (United States)

Author keywords

Azoles; De aromatization; Drugs; Furans; Heterocycles; Thiophenes

Indexed keywords

ANTIPROTOZOAL AGENT; CHOLINESTERASE INHIBITOR; FURAMIDINE; FURAN DERIVATIVE; HORMONE ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; OXAZOLE DERIVATIVE; OXYGEN; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PYRROLE DERIVATIVE; RECEPTOR BLOCKING AGENT; RETINOID X RECEPTOR ANTAGONIST; SALVINORIN A; SERTRALINE; SULFUR; THIAZOLE DERIVATIVE; THIOPHENE DERIVATIVE; UNCLASSIFIED DRUG;

CHEMICAL STRUCTURE; CHEMISTRY; DIABETES MELLITUS; DIELS ALDER REACTION; DRUG STRUCTURE; MEDICAL LITERATURE; POLYMERIZATION; REVIEW; SUBSTITUTION REACTION; SUZUKI REACTION; TRYPANOSOMIASIS;

AZOLES; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DESIGN; FURANS; HETEROCYCLIC COMPOUNDS; MOLECULAR STRUCTURE; PHARMACEUTICAL PREPARATIONS; THIOPHENES;

EID: 27844538344     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Joule JA, Mills K (Eds): Heterocyclic Chemistry - 4th Edition. Blackwell Publishing Ltd, Oxford, UK (2000). An excellent book that covers the synthesis and reactivity of all of the heterocyclic systems discussed in this review article.
2. Haffner CD, Lenhard JM, Miller AB, McDougald DL, Dwornik K, Ittoop OR, Gampe RT Jr, Xu HE, Blanchard S, Montana VG, Consler TG et al: Structure-based design of potent retinoid X receptor α agonists. J Med Chem (2004) 47(8):2010-2029.
3. Wang X, Bastow KF, Sun C-M, Lin Y-L, Yu H-J, Don M-J, Wu T-S, Nakamura S, Lee K-H: Antitumor agents. 239. Isolation, structure elucidation, total synthesis and anti-breast cancer activity of neotanshinlactone from Salvia miltiorrhiza. J Med Chem (2004) 47(23):5816-5819. Describes a key furan annulation in the late-stage synthesis of a natural product lead.
4. Tangallapally RP, Yendapally R, Lee RE, Hevener K, Jones VC, Lenaerts AJ, McNell MR, Wang Y, Franzblau S, Lee RE: Synthesis and evaluation of nitrofuranylamides as novel antituberculosis agents. J Med Chem (2004) 47(21):5276-5283.
5. Mitsch A, Wissner P, Silber K, Haebel P, Sattler I, Klebe G, Schlitzer M: Non-thiol farnesyltransferase inhibitors: N-(4-tolylacetylamino-3- benzoylphenyl)-3-arylfurylacrylic acid amides. Bioorg Med Chem (2004) 12(17):4585-4600. Reports a novel furan-containing farnesyltransferase inhibitor without a thiol unit.
6. Boros EE, Cowan DJ, Cox RF, Mebrahtu MM, Rabinowitz MH, Thompson JB, Wolfe LA 3rd: Hantzsch synthesis of pyrazolo[1′,2′:1,2]pyrazolo[3,4- b]pyridines: Partial agonists of the calcitonin receptor. J Org Chem (2005) 70(13):5331-5334. Describes the use of a Hantzch multi-component reaction with furyl and thiophenyl substituents.
7. Ismail MA, Brun R, Easterbrook JD, Tanious FA, Wilson WD, Boykin DW: Synthesis and antiprotozoal activity of aza-analogs of furamidine. J Med Chem (2003) 46(22):4761-4769.
8. 2 receptor agonist in vivo. J Med Chem (2004) 47(6):1536-1546.
9. Lutjens H, Zickgraf A, Figler H, Linden J, Olsson RA, Scammells PJ: 2-Amino-3-benzoylthiophene allosteric enhancers of A, adenosine agonist binding: New 3-, 4- and 5-modifications. J Med Chem (2003) 46(10):1870-1877. Describes the key use of a Gewald synthesis to assemble aminothiophenes.
10. Lisowski V, Leonce S, Kraus-Berthier L, Sopkova-de Oliveira Santos J, Pierre A, Atassi G, Caignard D-H, Renard P, Rault S: Design, synthesis and evaluation of novel thienopyrrolizinones as antitubulin agents. J Med Chem (2004) 47(6):1448-1464.
11. Lohray BB, Lohray VB, Srivastava BK, Kapadnis PB, Pandya P: Novel tetrahydro-thieno pyridyl oxazolidinone: An antibacterial agent. Bioorg Med Chem (2004) 12(17):4557-4564.
12. 10 antagonist activity: Chemistry and pharmacological evaluation of a series of thienopyran derivatives. Bioorg Med Chem (2004) 12(20):5277-5295. Describes an interesting and easily accessed thienylpyran heterocycle.
13. Cho H, Murakami K, Nakanishi H, Fujisawa A, Isoshima H, Niwa M, Hayakawa K, Hase Y, Uchida I, Watanabe H, Wakitani K et al: Synthesis and structure-activity relationships of 5,6,7,8-tetrahydro-4H-thieno[3,2-b]azepine derivatives: Novel arginine vasopressin antagonists. J Med Chem (2004) 47(1):101-109. Reports an interesting ring expansion, using thiophene as the migrating group.
14. Kumar PR, Raju S, Goud PS, Sailaja M, Sarma MR, Reddy GO, Kumar MP, Reddy VV, Suresh T, Hegde P: Synthesis and biological evaluation of thiophene [3,2-6] pyrrole derivatives as potential antiinflammatory agents. Bioorg Med Chem (2004) 12(5):1221-1230.
15. Wang M, Winneroski LL, Ardecky RJ, Babine RE, Brooks DA, Etgen GJ, Hutchison DR, Kauffman RF, Kunkel A, Mais DE, Montros-Rafizadeh C et al: Conversion of human-selective PPAR agonists to human/mouse dual agonists: A molecular modeling analysis. Bioorg Med Chem Lett (2004) 14(24):6113-6116.
16. Hattori K, Tabuchi S, Okitsu O, Taniguchi K: A simple stereoselective synthesis and biological evaluation of FR181157: Orally active prostacyclin mimetic. Bioorg Med Chem Lett (2003) 13(24):4277-4279.
17. Clausen RP, Moltzen EK, Perregaard J, Lenz SM, Sanchez C, Falch E, Frolund B, Bolvig T, Sarup A, Larsson OM, Schousboe A et al: Selective inhibitors of GABA uptake: Synthesis and molecular pharmacology of 4-N-methylamino-4,5,6,7-tetrahydro-benzo[d]-isoxazol-3-ol analogues. Bioorg Med Chem (2005) 13(3):895-908.
18. Falch E, Perregaard J, Frolund B, Sokilde B, Buur A, Hansen LM, Frydenvang K, Brehm L, Bolvig T, Larsson OM, Sanchez C et al: Selective inhibitors of glial GABA uptake: Synthesis, absolute stereochemistry and pharmacology of the enantiomers of 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2- benzisoxazole (exo-THPO) and analogues. J Med Chem (1999) 42(26):5402-5414.
19. Nazare M, Will DW, Matter H, Schreuder H, Ritter K, Urmann M, Essrich M, Bauer A, Wagner M, Czech J, Lorenz M et al: Probing the subpockets of Factor Xa reveals two binding models for inhibitors based on a 2-carboxyindole scaffold: A study combining structure-activity relationship and X-ray crystallography. (2005) 48(14):4511-4525.
20. Misra RN, Xiao H-Y, Williams DK, Kim KS, Lu S, Keller KA, Mulheron JG, Batorsky R, Tokarski JS, Sack JS, Kimball SD et at. Synthesis and biological activity of N-aryl-2-aminothiazoles: Potent pan inhibitors of cyclin-dependent kinases. Bioorg Med Chem Lett (2004) 14(11):2973-2977.
21. Cosford ND, Tehrani L, Roppe J, Schweiger E, Smith ND, Anderson J, Bristow L, Brodkin J, Jiang X, McDonald I, Rao S et al: 3-[(2-Methyl-1,3- thiazol-4-yl)ethynyl]-pyridine: A potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity. J Med Chem (2003) 46(2):204-206.
22. Wright DL: Furans as versatile synthons for target-oriented and diversity-oriented synthesis. In: Progress in Heterocyclic Chemistry - Volume 17. Gribble GW, Joule JA (Eds), Elsevier, Oxford, UK (2005):1-32. Review of methods for the conversion of furans to non-aromatic building blocks.
23. Hart ME, Chamberlin AR, Walkom C, Sakoff JA, McCluskey A: Modified norcantharidins: Synthesis, protein phosphatases 1 and 2A inhibition and anticancer activity. Bioorg Med Chem Lett (2004) 14(8):1969-1973. Describes the direct application of a furan Diels-Alder reaction in drug development.
24. To KK, Wang X, Yu CW, Ho Y-P, Au-Yeung SC: Protein phosphatase 2A inhibition and circumvention of cisplatin cross-resistance by novel TCM-platinum anticancer agents containing demethyl-cantharidin. Bioorg Med Chem (2004) 12(17):4565-4573.
25. Ho Y-P, To KK, Au-Yeung SC, Wang X, Lin G, Han X: Potent new antitumor agents from an innovative combination of demethylcantharidin, a modified traditional Chinese medicine, with a platinum moiety. J Med Chem (2001) 44(13):2065-2068.
26. Lautens M, Rovis T: General strategy toward the tetrahydronaphthalene skeleton. An expedient total synthesis of sertraline. J Org Chem (1997) 62(16):5246-5247. Reports the use of furan in the synthesis of a commercial therapeutic agent.
27. Hjelmgaard T, Persson T, Rasmussen TB, Givskov M, Nielsen J: Synthesis of furanone-based natural product analogs with quorum sensing antagonist activity. Bioorg Med Chem (2003) 11(15):3261-3271.
28. Razet R, Thomet U, Furtmueller R, Chiaroni A, Sigel E, Sieghart W, Dodd RH: 5-[1′-(2′-N-Arylsulfonyl-1′,2′,3′,4′- tetrahydroisoquinolyl)]-4,5-dihydro-2(3H)-furanones: Positive allosteric modulators of the GABAA receptor with a new mode of action. J Med Chem (2000) 43(23):4363-4366.
29. Hanessian S, Therrien E, Granberg K, Nilsson I: Targeting thrombin and Factor VIIa: Design, synthesis and inhibitory activity of functionally relevant indolizidinones. Bioorg Med Chem Lett (2002) 12(20):2907-2911. Discusses the use of a furan as a precursor to a butenolide.
30. Munro TA, Rizzacasa MA, Roth BL, Toth BA, Yan F: Studies toward the pharmacophore of salvinorin A, a potent κ-opioid receptor agonist. J Med Chem (2005) 48(2):345-348.
31. 2 subtype antagonistic activity of the novel himbacine congeners modified at the C-3 position of lactone moiety. Bioorg Med Chem (2003) 11(7):1169-1186.
32. Nanduri S, Thunuguntla SSR, Nyavanandi VK, Kasu S, Kumar PM, Ram PS, Rajagopal S, Kumar RA, Deevi DS, Rajagopalan R, Venkateswarlu A: Biological investigation and structure-activity relationship studies on azadirone from Azadirachta indica A. Juss. Bioorg Med Chem Lett (2003) 13(22):4111-4115.
33. Burke MD, Berger EM, Schreiber SL: A synthesis strategy yielding skeletally diverse small molecules combinatorially. J Am Chem Soc (2004) 126(43):14095-14104. Describes the use of furans to build skeletal diversity in a library.
34. Doucet-Personeni C, Bentley PD, Fletcher RJ, Kinkaid A, Kryger G, Pirard B, Taylor A, Taylor R, Taylor J, Viner R, Silman I et al: A structure-based design approach to the development of novel, reversible AChE Inhibitors. J Med Chem (2001) 44(20):3203-3215.
35. Mohr JT, Gribble GW, Lin SS, Eckenhoff RG, Cantor RS: Anesthetic potency of two novel synthetic polyhydric alkanols longer than the n-alkanol cutoff: Evidence for a bilayer-mediated mechanism of anesthesia? J Med Chem (2005) 48(12):4172-4176.